Hyperfine And Liminal Sciences Combine To Go Public Via SPAC Deal
HealthCor Catalio Acquisition Corp, is acquiring Hyperfine, a developer of portable magnetic resonance imaging systems, and Liminal Sciences, which is focused on non-invasive brain monitoring. The new public company will also be called Hyperfine.
You may also be interested in...
Pear has commercialized FDA-cleared prescription digital therapeutics for substance abuse disorder, opioid use disorder and chronic insomnia and has 14 more in development. CEO Corey McCann explained Pear’s vision for how PDTs can transform health care.
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
Vicarious Surgical, whose medical robot received US FDA breakthrough designation, announced it will merge with D8 Holdings Corp. The deal is expected to garner up to $460m.